Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05683392 · ClinicalTrials.gov registry record · NA
Use of Control-IQ Technology 2.0 in Adults, Children, and Preschoolers With Type 1 Diabetes
A NA study, sponsored by Tandem Diabetes Care.
- Completed
- Registry status
- NA
- Development phase
- 72
- Enrollment target
NCT05683392 is a NA study that has completed, run by Tandem Diabetes Care. The registered enrollment target is 72 participants.
The verdict
NCT05683392, a NA study, has completed, sponsored by Tandem Diabetes Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to assess safety of and explore glycemic outcomes with Control-IQ technology 2.0 in adults, children and preschoolers with type 1 diabetes.
Interventions
- DEVICE t:slim X2 insulin pump with Control-IQ technology 2.0
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2023-02-01 |
| Est. Completion | 2023-12-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05683392
The ClinicalTrials.gov registry entry for NCT05683392 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tandem Diabetes Care, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which t:slim X2 insulin pump with Control-IQ technology 2.0 is the first listed.
NCT05683392 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05683392 about?
NCT05683392 is a clinical study titled "Use of Control-IQ Technology 2.0 in Adults, Children, and Preschoolers With Type 1 Diabetes". The goal of this clinical trial is to assess safety of and explore glycemic outcomes with Control-IQ technology 2.0 in adults, children and preschoolers with type 1 diabetes.
What is the current status of trial NCT05683392?
This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2023-02-01. Estimated completion is 2023-12-13.
What interventions are being tested in trial NCT05683392?
The interventions under investigation include: t:slim X2 insulin pump with Control-IQ technology 2.0 (DEVICE).
Who is sponsoring clinical trial NCT05683392?
This trial is sponsored by Tandem Diabetes Care, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.